Oliver A. Cornely

Oliver Andreas Cornely (born January 6, 1967 in Cologne ) is a German specialist in internal medicine, hematology, internal oncology and infectious diseases as well as professor of medicine and translational research at Cologne University Hospital .

Life

Cornely studied medicine in Cologne from 1987 to 1994. From 1994 to 1995 he was an intern in the ward service of hematology and oncology at Clinic I for Internal Medicine at Cologne University Hospital, where he worked as an assistant doctor from 1995 to 1996. This was followed by activities as a ward doctor and, from 2006, as a senior physician. Cornely received his doctorate in 1999 on the epidemiology, clinical features and etiology of the bile duct manifestations of HIV-infected patients and completed his habilitation in 2004 on the development of oral monotherapy from the parenteral combination therapy of neutropenic fever . From 2005 to 2014 he was Deputy Head of Clinical Infectious Diseases. From 2007 to 2014 he was the medical director of the Center for Clinical Studies in Cologne at the University of Cologne, which he has been Head of as academic director ever since.

Since March 2008 Cornely has been an associate professor for internal medicine.

From 2008 to 2011 he was President of the German-speaking Mycological Society (DMykG). He is study coordinator of the European Fungal Infection Study Group (EFISG). From 2011 to 2017 he was President of the European Society for Mycology (Fungal Diseases) and founded the Academy and the Excellence Program of the ECMM in 2016. Since 2014 he has been a university professor and holder of the translational research chair in the CECAD cluster of excellence .

Since 2017 he has headed the ECMM Diamond Excellence Center (Center of Excellence for Invasive Fungal Diseases) at the University Hospital Cologne. As of 2018, Cornely is head of the prophylaxis working group of the AG infections of the German Society for Hematology and Oncology (DGHO) and the working group infections in hematology of the European Hematological Association (EHA). He is the coordinator of the clinical study unit of the German Center for Infection Research (DZIF). Cornely is a board member of the U.S. Mycoses Study Group Education and Research Consortium (MSG ERC) and was elected to the board of the International Society for Human and Animal Mycology (ISHAM) in June 2018.

Research priorities

Cornely's scientific research focuses on clinical infectious diseases , especially in the development of new diagnostic and therapeutic methods for invasive mycoses and abdominal infections. In 2003 he founded the FungiScope registry study for neglected rare infections, in which centers from 66 countries around the world are now involved. Cornely has been involved in more than 200 clinical studies and is the author of over 300 specialist articles in peer-reviewed journals.

Since 2016, Cornely has been involved as a mentor in the “Welcome” scholarship program for refugees of the German University Association .

Awards (selection)

• 2003: European Society for Medical Oncology Masterclass Scholarship
• 2007: Publication Prize of the German-speaking Mycological Society
• 2008: Fellow of the Infectious Diseases Society of America
• 2009: Faculty Award of the Medical Faculty of the University of Cologne
• 2011: Fellow of the American College of Physicians
• 2014: Prof. Pushpa Talwar Memorial Oration / Post Graduate Institute of Medical Education and Research, Chandigarh, India
• 2015: Fellow of the American Academy of Microbiology
• 2016: Fellow of the European Confederation of Medical Mycology
• 2018: Rated Top 1% Most Influential Researchers

Web links

• Short biography of Oliver Cornely and Oliver Cornely working group , University Hospital Cologne
• Publications Pubmed.gov
• CEDAD profile Oliver Cornely Oliver Cornely